Pepti · Catalog · Cagrilintide

GLP-1 family · research-use

Cagrilintide OEM supply.
Research use, worldwide.

Lyophilized cagrilintide (long-acting amylin analog research compound) for research labs and private-label brand evaluation worldwide. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record.

!
Research use — supplied as research peptides; buyers confirm local compliance

On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework, with public comment open through 2026-06-29. Pending finalization, this compound is positioned for research and private-label brand evaluation worldwide. Read the GLP-1 2026 update →

Cagrilintide lyophilized vial
Lot CAG-5HPLC ≥ 99%MS confirmed5 / 10 mg

Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.

CompoundCagrilintide
CAS number1415456-99-3
ClassLong-acting amylin analog (research)
Molecular weightConfirmed on batch-linked COA for each production lot
FormLyophilized powder, glass vial
Purity target≥ 99% by HPLC
Vial formats5 mg, 10 mg (custom on request)
DocumentationBatch-linked COA + HPLC chromatogram + MS identity record for every production lot
Distribution scopeResearch use, worldwide
Storage2–8 °C protected from light; long-term −20 °C

MOQ & lead time

TierQuantityLead time
Sample lotFrom 100 vials5–10 days
Production lot500–2,000 vials14–21 days
OEM repeat2,000+ vials21–28 days, scheduled

Cagrilintide is most often quoted alongside semaglutide in research stacks. All quotes require a destination country and buyer track.

Documentation

Every Cagrilintide lot ships with a batch document pack for the production lot.

COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.

HPLC purity

Reverse-phase HPLC with UV detection; ≥99% area-purity target on each production lot.

MS identity

Mass spectrometry identity confirmation against the Cagrilintide reference profile.

Lot traceability

Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.

FAQ

Common Cagrilintide questions from B2B buyers.

How is cagrilintide supplied?

On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework. While cagrilintide is an amylin analog, Pepti supplies it as a research peptide worldwide; buyers confirm local compliance.

Is cagrilintide often paired with semaglutide?

Yes — the amylin + GLP-1 stack is a common research / private-label evaluation pair. Both can be quoted together in the Quote Cart.

Which markets do you serve?

Latin America, Southeast Asia, parts of the Middle East, and select EMEA distributors with appropriate local registration.

What is the MOQ?

Sample lots from 100 vials; production lots from 500 vials with tier pricing.

What does your COA report?

HPLC purity (target ≥99%), MS identity, water content, related-substance profile on request, and lot traceability.

WhatsApp us